Cesar A. Moran, MD
Pathologist
Asbestosis Clubbed Fingers Diffuse Pleural Thickening Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Rounded Atelectasis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
A pathology professor at the University of Texas MD Anderson Cancer Center, Dr. Cesar Moran finished his medical studies at the University of San Carlos Medical School in Guatemala, in 1981. Dr. Moran was a resident at the Mount Sinai Hospital, and completed a fellowship in surgical pathology at the Yale University School of Medicine. His specialty is research and treatment of mesothelioma. With several research articles reviewed by peers and published in medical journals, and having been named Distinguished Teaching Professor at the University of Texas, Dr. Moran’s research in the treatment of mesothelioma has been invaluable to the medical community.
University of San Carlos Medical School - 1981
Medical School
Mount Sinai Hospital
Residency
Yale University School of Medicine
Fellowship
American Board of Pathology
University of Texas MD Anderson Cancer Center
Languages: English/Spanish
713-792-2121
1515 Holcombe Blvd
Read MoreCystic well-differentiated squamous cell carcinoma of the thymus: a clinicopathological and immunohistochemical study of six cases.
Weissferdt A, Kalhor N, Moran CA.
See more >>An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Zenali MJ, Weissferdt A, Solis LM, Ali S, Tang X, Mehran RJ, Wistuba II, Moran CA, Kalhor N.
See more >>EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.
Behrens C, Solis LM, Lin H, Yuan P, Tang X, Kadara H, Riquelme E, Galindo H, Moran CA, Kalhor N, Swisher SG, Simon GR, Stewart DJ, Lee JJ, Wistuba II.
See more >>College of American Pathologists